Wednesday, June 07, 2006 11:41:43 PM
http://www.biofrontera.com/cms/index.php?id=25
Looks a little sooner to those of us with brains...lol
Scroll down and take a look at the Supervisory Board. A couple of new names...very interesting:
David Ebsworth, PhD - former Head of Bayer's North American Pharmaceutical Operations. Current Chairman of Curacyte AG, Non-Executive Director at both Curagen and SkyePharma:
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/10-20-1999/0001048737&...
http://80.243.45.221:8080/opencms/opencms/curacyte/directors.htm
http://diplomacy.shu.edu/world_leaders/gala/
http://www.curagen.com/corporate/manage.asp#bod
http://www.skyepharma.com/management.html
Has the look of a real heavyweight, wouldn't you say LULU? Oh, and note that he will be replacing Professor Abshagen, who is retiring from the board "AFTER THE IPO".
I just can't figure out what he would be doing with Biofrontera. Maybe he's just...how did Dr. Wacky put it..."aligning himself with a small wannabe engaged by DNAG management for cosmetic publicity?"
Later,
W2P
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM